Luprodex 11.25 mg Injection 2 ml Substitute
by Others
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
LEUPRORELIN-11.25MG
Uses:
Prostate cancer, Breast cancer, Endometriosis, Premature puberty
Medicinal Benefits:
Luprodex 11.25 mg Injection 2 ml contains Leuprorelin which works similarly to the natural hormone, gonadotropin-releasing hormone (GnRH), by acting on the pituitary gland and decreasing the levels of testosterone in men and oestrogen in women. Thereby, Luprodex 11.25 mg Injection 2 ml is used in the treatment of prostate cancer by inhibiting the growth of the tumour or causing it to shrink. Also, Luprodex 11.25 mg Injection 2 ml is used to treat hormone-responsive breast cancer in pre and postmenopausal women. By reducing testosterone and oestrogen levels, Luprodex 11.25 mg Injection 2 ml delays the onset of puberty in children.
Luprodex 11.25 mg Injection 2 ml contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Luprodex 11.25 mg Injection 2 ml is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.
Luprodex 11.25 mg Injection 2 ml may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.
Luprodex 11.25 mg Injection 2 ml should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Luprodex 11.25 mg Injection 2 ml and inform your doctor if you have diabetes before taking Luprodex 11.25 mg Injection 2 ml.
Luprodex 11.25 mg Injection 2 ml may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Luprodex 11.25 mg Injection 2 ml reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.
Luprodex 11.25 mg Injection 2 ml may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Luprodex 11.25 mg Injection 2 ml.
Luprodex 11.25 mg Injection 2 ml should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Luprodex 11.25 mg Injection 2 ml.